Development and validation of a quantitative real-time PCR assay using fluorescence resonance energy transfer technology for detection of Aspergillus fumigatus in experimental invasive pulmonary aspergillosis

被引:64
作者
O'Sullivan, CE [1 ]
Kasai, M [1 ]
Francesconi, A [1 ]
Petraitis, V [1 ]
Petraitiene, R [1 ]
Kelaher, AM [1 ]
Sarafandi, AA [1 ]
Walsh, TJ [1 ]
机构
[1] NCI, Immunocompromised Host Sect, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1128/JCM.41.12.5676-5682.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Invasive pulmonary aspergillosis (IPA) is a frequently fatal infection in immunocompromised patients that is difficult to diagnose. Present methods for detection of Aspergillus spp. in bronchoalveolar lavage (BAL) fluid and in tissue vary in sensitivity and specificity. We therefore developed an A. fumigatus-specific quantitative real-time PCR-based assay utilizing fluorescent resonance energy transfer (FRET) technology. We compared the assay to quantitative culture of BAL fluid and lung tissue in a rabbit model of experimental IPA. Using an enzymatic and high-speed mechanical cell wall disruption protocol, DNA was extracted from samples of BAIL fluid and lung tissues from noninfected and A. fumigatus-infected rabbits. A unique primer set amplified internal transcribed spacer regions (ITS) I and 2 of the rRNA operon. Amplicon was detected using FRET probes targeting a unique region of ITS1. Quantitation of A. fumigatus DNA was achieved by use of external standards. The presence of PCR inhibitors was determined by use of a unique control plasmid. The analytical sensitivity of the assay was less than or equal to10 copies of target DNA. No cross-reactivity occurred with other medically important filamentous fungi. The assay results correlated with pulmonary fungal burden as determined by quantitative culture (r = 0.72, Spearman rank correlation; P less than or equal to 0.0001). The mean number of genome equivalents detected in untreated animals was 3.86 log(10) (range, 0.86 to 6.39 log(10)) in tissue. There was a 3.53-log(10) mean reduction of A. fumigatus genome equivalents in animals treated with amphotericin B (AMB) (95% confidence interval, 3.38 to 3.69 log(10); P less than or equal to 0.0001), which correlated with the reduction of residual fungal burden in lung tissue measured in terms of log(10) CFU/gram. The enhanced quantitative sensitivity of the real-time PCR assay was evidenced by detection of A. fumigatus genome in infarcted culture-negative lobes, by a greater number of mean genome equivalents compared to the number of CFU per gram in tissue and BAL fluid, and by superior detection of therapeutic response to AMB in BAL fluid compared to culture. This real-time PCR assay using FRET technology is highly sensitive and specific in detecting A. fumigatus DNA from BAL fluid and lung tissue in experimental IPA.
引用
收藏
页码:5676 / 5682
页数:7
相关论文
共 26 条
[1]   PATHOGENESIS OF PULMONARY ASPERGILLOSIS - GRANULOCYTOPENIA VERSUS CYCLOSPORINE AND METHYLPREDNISOLONE-INDUCED IMMUNOSUPPRESSION [J].
BERENGUER, J ;
ALLENDE, MC ;
LEE, JW ;
GARRET, K ;
LYMAN, C ;
ALI, NM ;
BACHER, J ;
PIZZO, PA ;
WALSH, TJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (03) :1079-1086
[2]   Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients [J].
Buchheidt, D ;
Baust, C ;
Skladny, H ;
Baldus, M ;
Bräuninger, S ;
Hehlmann, R .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (04) :803-811
[3]   Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction:: Clinical results [J].
Buchheidt, D ;
Baust, C ;
Skladny, H ;
Ritter, J ;
Suedhoff, T ;
Baldus, M ;
Seifarth, W ;
Leib-Moesch, C ;
Hehlmann, R .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (04) :428-435
[4]  
BURNETT JH, 1975, MYCOGENETICS INTRO G
[5]   Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery [J].
Caillot, D ;
Casasnovas, O ;
Bernard, A ;
Couaillier, JF ;
Durand, C ;
Cuisenier, B ;
Solary, E ;
Piard, F ;
Petrella, T ;
Bonnin, A ;
Couillault, G ;
Dumas, M ;
Guy, H .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) :139-147
[6]   EFFICACY OF UNILAMELLAR LIPOSOMAL AMPHOTERICIN-B IN TREATMENT OF PULMONARY ASPERGILLOSIS IN PERSISTENTLY GRANULOCYTOPENIC RABBITS - THE POTENTIAL ROLE OF BRONCHOALVEOLAR D-MANNITOL AND SERUM GALACTOMANNAN AS MARKERS OF INFECTION [J].
FRANCIS, P ;
LEE, JW ;
HOFFMAN, A ;
PETER, J ;
FRANCESCONI, A ;
BACHER, J ;
SHELHAMER, J ;
PIZZO, PA ;
WALSH, TJ .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) :356-368
[7]   Evaluation of different methods for the extraction of DNA from fungal conidia by quantitative competitive PCR analysis [J].
Haugland, RA ;
Heckman, JL ;
Wymer, LJ .
JOURNAL OF MICROBIOLOGICAL METHODS, 1999, 37 (02) :165-176
[8]   Detection of Aspergillus species DNA by PCR in bronchoalveolar lavage fluid [J].
Hayette, MP ;
Vaira, D ;
Susin, F ;
Boland, P ;
Christiaens, G ;
Melin, P ;
De Mol, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (06) :2338-2340
[9]   Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients [J].
Herbrecht, R ;
Letscher-Bru, V ;
Oprea, C ;
Lioure, B ;
Waller, J ;
Campos, F ;
Villard, O ;
Liu, KL ;
Natarajan-Amé, S ;
Lutz, P ;
Dufour, P ;
Bergerat, JP ;
Candolfi, E .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) :1898-1906
[10]   Comparison between PCR and detection of antigen in sera for diagnosis of pulmonary aspergillosis [J].
Kawamura, S ;
Maesaki, S ;
Noda, T ;
Hirakata, Y ;
Tomono, K ;
Tashiro, T ;
Kohno, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (01) :218-220